MHRA: Business Impact Target
The Medicines and Healthcare products Regulatory Agency (MHRA) assesses its regulatory impact on businesses.
Documents
Details
The business impact target (BIT) is a cross-government target for the reduction of regulation on business.
Under the BIT, MHRA assesses the financial impacts on business of qualifying regulatory provisions (QRPs). QRPs are changes to regulatory practices that are described in a written ministerial statement. We assess the impacts of these changes through BIT assessments.
Any measure that falls within the +/-£5 million de minimis threshold will be out of scope of the BIT, and written up in the Non-Qualifying Regulatory provision (NQRP) summary template.
Between 13 December 2019 – 16 December 2020, there were no measures that came into force above the +/-£5m de minimis threshold; summaries of the MHRA’s NQRPs are available further above.
Updates to this page
Published 8 June 2017Last updated 19 December 2022 + show all updates
-
Added 'MHRA NQRP Summary 2021/22'
-
Added MHRA NQRP Summary 2020/21
-
Added MHRA NQRP Summary 2019/20
-
MHRA Non-Qualifying Regulatory provision (NQRP) Business Impact Target for 2018/19 added to the page.
-
Merged 2016/17 documents and minor re-wording to the text describing the documents available.
-
Added NQRP Summary for 2017/18. Also added new information about no new measures coming into force between June 2017 and June 2018.
-
Updated MHRA NQRP Year 2 summary
-
Added three validated RPC opinions.
-
First published.